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INTRODUCTION
The induction of memory T cells is a key focus in the development of vaccines and immunotherapies directed toward infectious pathogens and tumors (1, 2) . The primary T cell response to acutely infecting pathogens is marked by rapid proliferation and the development of key effector functions. After pathogen clearance, 90 to 95% of effector T cells die, leaving behind a long-lived population of memory T cells (3, 4) . CD8 + effector T cells that are memory precursors can be identified by the expression of cell surface markers such as interleukin-7R (IL-7R) (5) , and some progress has been made in identifying memory precursor CD4 + T cells (6) . However, the specific signals and mechanisms that dictate CD4 + memory T cell fate commitment during the effector response remain elusive.
External differentiation cues, such as cytokines, play a well-known role in controlling T helper subset effector and memory differentiation. However, cell-intrinsic signals mediated by the T cell receptor (TCR) also control many aspects of CD4 + T cell differentiation. CD4 + T cells require multiple interactions with their cognate antigen to successfully differentiate into competent effector (7, 8) and memory (9) T cells. Several lines of evidence indicate that strong TCR signals favor T helper 1 cell (T H 1) differentiation both in vitro (10) and in vivo (11) . In addition, T H 1 differentiation is associated with enhanced CD25 expression (12) , an early activation marker driven by TCR signaling. In contrast, T follicular helper cell (Tfh) specification has been associated, in separate studies, with high-affinity TCRs or TCRs with long dwell times (13, 14) , and occupation of multiple immunoreceptor tyrosine-based activation motifs on a single CD3 is also required for Tfh differentiation (15) . Monoclonal T cell populations responding to the same epitope can also produce heterogeneous TCR signals, leading to differential effector fates (11, 12) . The TCR-dependent early activa tion molecules IL-2 and IL-2R (CD25) are also implicated in T helper differentiation. Exogenous IL-2 treatments (16) or analysis of early CD25 expression profiles (12) has highlighted a key temporal role for IL-2 signaling in T helper differentiation. A key downstream transcription factor of IL-2 signaling, signal transducer and activator of transcription 5, has been shown to drive T H 1 development (17) , and IL-2 and IL-21 have been shown to promote T H 1 and Tfh differentiation, respectively, although it is not clear whether the effect is paracrine or autocrine (18, 19) .
Because TCR molecules are themselves highly variable, the antigenspecific response to an infection is marked by a high level of clonal diversity (20, 21) . However, this diversity is subject to a process of selection, as shown by our previous finding that not all T cell clones give rise to memory cells with equal efficiency after acute infection with lymphocytic choriomeningitis virus (LCMV) or Listeria monocytogenes (22) . The goal of the current study is to acquire a better understanding of the TCR signals propagated by "memory-biased" versus "effectorbiased" T cell clones during the polyclonal response.
We analyzed a panel of previously cloned TCRs, all recognizing the same major histocompatibility complex (MHC) class II-restricted epitope, glycoprotein 61-80 (GP 61-80 ) of LCMV, and each with a previously defined contribution to the CD4 + memory T cell pool during an in vivo polyclonal response. We found that overall TCR signal strength inversely corresponded to the contribution of each TCR to the formation of T cell memory. During in vivo infection with LCMV, the extent of both  chain-associated protein kinase 70 (ZAP-70) phosphorylation and CD25 expression at early effector time points inversely corresponded to memory potential. Heterogeneous CD25 expression predicted a bias in the formation of T H 1 and Tfh populations. CD25 lo effector cells gave rise to a mix of T H 1 and Tfh  effector cells, as well as most T H 1-like and Tfh-like memory cells,  whereas CD25 hi early effector cells gave rise almost exclusively to terminally differentiated effector T H 1 cells. This differential T cell fate was further supported through global transcriptional analysis. Direct modulation of TCR signaling via the short hairpin RNA (shRNA)-mediated knockdown (KD) of the Src homology region 2 domaincontaining phosphatase 1 (SHP-1) additionally biased the response toward the differentiation of effector T H 1 cells, indicating that TCR signal strength shapes the differential formation of both effector and memory CD4 + T cells with Tfh or T H 1 characteristics. S1C ). The TCR-dependent NFAT activity, as measured by GFP induced by each cell line, was highly heterogeneous and inversely corresponded to our previous assessment of the memory potential of each TCR (Fig. 1, A and B, and fig. S1C ). TCRs previously shown to have lower representation in the memory compartment, as compared with the peak of the effector response (Mem Lo ; fig. S1A ), induced significantly higher levels of GFP than TCRs previously shown to have equal or higher representation in the memory compartment, as compared with the peak of the effector response (Mem Hi; fig. S1A ). Similar results were found when we assessed NFB-induced CFP expression (Fig. 1B) . We also measured TCR-dependent gene expression. After 24 hours of stimulation, induction of CD25 surface expression corresponded to GFP expression (Fig. 1C) .
RESULTS

Heterogeneous induction of TCR signals in vitro corresponds
To further explore differences in TCR signaling in the context of primary T cell activation, we created two transgenic mouse lines expressing TCRs that recognize GP 61-80 of LCMV (C7 and C26). C7 CD4 + T cells displayed diminished phosphorylation of ZAP-70 and CD3 after 1 hour of coincubation with pepDCs, as compared with C26 cells (fig. S2, A and B) . In addition, C7 T cells expressed lower levels of the TCR-dependent activation marker CD25 than did C26 T cells after 24 hours of stimulation ( fig. S2C ). We also performed reverse transcription polymerase chain reaction (RT-PCR) on RNA extracted from C7 or C26 splenocyte cultures that had been stimulated with 0.1 M GP 61-80 for 1 to 3 days, with particular focus on genes immediately up-regulated after TCR activation (Il2 and Nfatc1) or involved in effector function (Tbx21 and Ifng). C26 T cells demonstrated increased expression of Nfatc1 and Il2 by day 3 of culture ( fig. S2D ). C26 T cells also expressed higher levels of Ifng and Tbx21 transcripts at days 1 and 3 of culture ( fig. S2D ). Previous studies have suggested that strong TCR signals promote enhanced T H 1 differentiation, and our findings are consistent with that premise (11, 26) . These findings confirm heterogeneous TCR signaling and TCR-dependent activation induced by two TCRs that recognize the same immunodominant epitope.
Interclonal differences in TCR signal strength and CD25 expression predict effector and memory differentiation In our previous studies, we used SM mice to establish a role for the TCR in regulating CD4 + memory T cell differentiation. We observed that memory-biased TCRs (represented at higher frequencies at memory time points than at effector time points) were enriched for V14 + T cells, whereas effector-biased TCRs (represented at higher frequencies at effector time points than at memory time points) were enriched for V7 + T cells (20) . We took advantage of this observation to assess the expression of CD25 on effector T cells that were more or less likely to give rise to memory T cells. We infected SM mice with LCMV, followed by detection of GP 66-77 tetramer-binding CD4 + T cells in the spleen at day 5 post-infection. We found that responding V14 + effector cells were less likely to express CD25 than the tetramer-binding population as a whole, whereas V7 + effector cells were more likely to express CD25 ( Fig. 2A) . T-bet expression was also higher in the V7 + effector cells (Fig. 2B) , leading to the conclusion that, within a monoclonal population, CD25 lo effector cells were more likely to give rise to memory T cells, whereas CD25
hi effector cells were enriched for terminally differentiated T H 1 cells. We additionally assessed the expression of CD25 in early effector cells derived from a polyclonal T cell repertoire in wild-type (WT) mice. At day 5 post-infection, we observed highly variable CD25 expression within activated (IA b -GP 66-77 tetramer + , CD44 + ) CD4 + T cells ( fig. S3 ), indicating that CD25 expression is broadly heterogeneous during a physiologic T cell response in vivo.
We next asked whether clonal differences in TCR signal strength predicted memory formation in vivo. We performed a clone-byclone analysis by generating several TCR retrogenic T cell lines as previously described ( fig. S1A) (20, 27, 28) , adoptively transferring them into B6 mice and infecting them with LCMV 1 day later. For each of the four clones tested (5, 7, 26, 27) , we observed heterogeneity in the phosphorylation of ZAP-70 and the expression of CD25 by day 3 post-infection (Fig. 2C) . We further measured the number of peak effector (day 8) and memory cells (day 42) for each clone. We ) at day 3 post-infection to % survival for each Rg TCR, as determined by Pearson's correlation. Error bars indicate the SEM, and statistical significance was determined by Student's t test (n = 3 to 5 mice per group, representative of at least two independent experiments). *P < 0.05, **P < 0.01.
found that reduced expression of phosphorylated ZAP-70 (pZAP-70) at day 3 in clones 5 and 7, as compared with clones 26 and 27, significantly corresponded to the proportion of resulting peak effector cells that gave rise to memory cells (Fig. 2D) . A significantly smaller proportion of clone 5 T cells expressed high levels of CD25 as compared with clones 26 and 27, whereas clone 7 displayed an intermediate phenotype (Fig. 2C ). CD25 also corresponded to memory formation, although in this case, the differences indicated a trend only (Fig. 2D ).
Differences in CD25 expression correspond to differences in TCR signal strength in vivo
We next used an adoptive transfer model in which WT mice (Thy1.2 + ) received an intravenous injection of SMARTA TCR transgenic CD4 + T cells (Thy1.1 + ), followed by infection with LCMV 1 day later. SMARTA T cells showed uniform patterns of CD25 expression through day 2 post-infection, with almost all activated T cells expressing high levels of CD25 by day 2. However, by day 3, a proportion of SMARTA T cells expressed low levels of CD25, and this bimodal expression persisted through day 5. We found similar results when assessing the expression of CD25 by C7 and C26 T cells after LCMV infection. In addition, the proportion of CD25 lo early effector cells was significantly different when comparing C7 and C26 at day 3 post-infection ( fig. S4A ), similar to the clonal differences in CD25 expression observed for retrogenic T cell clones (Fig. 2) . Differences in CD25 expression did not coincide with differences in the expression of classical activation markers CD44 and CD62L or secretion of the effector cytokines interferon- (IFN-), tumor necrosis factor-, and IL-2 ( fig. S4B ).
CD25 surface expression predicted differences in effector differentiation. CD25
hi early SMARTA effector cells (day 3 post-infection) in the spleen expressed phenotypic markers indicative of T H 1 differentiation [lymphocyte antigen 6 complex, locus C1 (Ly6C) and T cell immunoglobulin and mucin-domain containing-3 (Tim-3)] that were largely absent on CD25 lo effector cells (Fig. 3B ). CD25 hi SMARTA early effector cells additionally expressed higher levels of T-bet (Fig. 3C) , whereas CD25 lo effector cells expressed increased levels of the Tfh markers CXCR5 and T cell factor 1 (TCF-1; Fig. 3C ). Furthermore, CD25
hi effector cells in the spleen expressed higher levels of pZAP-70 at days 3 and 5 post-infection (Fig. 3D ).
CD25 surface expression predicts memory potential
Given the heterogeneity of TCR signaling and CD25 expression even within monoclonal populations, we tested whether CD25 surface expression by early effector cells predicted effector and memory differentiation. Several lines of evidence suggested this possibility. First, CD25 expression distinguished CD8 + effector T cells likely to undergo terminal effector differentiation from those that give rise to memory T cells (29) . Second, Blimp-1 expression by early CD4 Error bars indicate the SEM, and statistical significance was determined by Student's t test (n = 4 mice per group, representative of four independent experiments). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
effector T cells inversely corresponded to memory potential, and CD25 was strongly coexpressed with Blimp-1 in those studies (12) . Third, in vitro induction of CD25 driven by TCR signal strength strongly corresponded to increasing T H 1 polarization (Fig. 3, C and D, and fig. S2D ). We isolated CD25 hi and CD25 lo SMARTA effector cells at days 3 or 5 post-infection and transferred them into separate infectionmatched B6 hosts in equal numbers (Fig. 4A) . Although both populations continued to expand, the vast majority of circulating and spleen-residing memory cells were derived from the CD25 lo effector popula tion as early as day 3 post-infection (Fig. 4, B and C) . In contrast, both CD25 lo and CD25 hi early effector cells gave rise to liver-residing memory T cells (Fig. 4C) with similar efficiency. This may reflect the reported role for IL-2 in the establishment of tissue-residing CD4 + memory T cells (30, 31) , although the interpretation is made complex by the temporal changes that we observed in high-affinity IL-2R expression (Fig. 3A) . We used an additional retrogenic T cell line (clone 18), generated as previously described ( fig. S1 ), to perform similar adoptive transfer experiments. As with SMARTA T cells, CD25 lo clone 18 early effector cells similarly gave rise to most memory T cells ( fig. S5, A and B) , indicating that CD25 expression predicts memory differentiation across multiple clones.
CD25 expression at early effector time points further predicted T helper differentiation at the peak of the effector response (day 8).
CD25
hi early effector cells gave rise to mostly T H 1 cells at day 8 postinfection, as measured by increased expression of Ly6C and T-bet. In contrast, CD25 lo cells gave rise to mostly Tfh effector cells at day 8 post-infection, as measured by expression of CXCR5, programmed cell death protein 1 (PD-1), and B cell lymphoma 6 protein (Bcl-6) (Fig. 4, D hi effector cells expressed increased T-bet (Fig. 4F) , consistent with the differentiation of effector memory cells. These results indicate a role for TCR signaling in driving both memory and effector CD4 + T cell differentiation.
CD25 expression during the primary response does not predict memory T cell function
To test the memory function of CD25 hi -or CD25 lo -derived SMARTA memory cells, we isolated SMARTA cells at day 42 after primary LCMV infection, transferred them into naïve hosts, and rechallenged them with LCMV (Fig. 5A) . At the peak of their secondary response (day 5 post-infection), both CD25 lo -and CD25 hi -derived SMARTA memory cells had undergone similar levels of clonal expansion (Fig. 5B) . We observed no differences in secondary T helper differentiation, as shown by expression of CXCR5, PD-1, Ly6C, Bcl-6, and T-bet (Fig. 5, C and D) . We concluded that, although CD25 lo and CD25 hi early effector cells gave rise to different numbers of memory cells, secondary expansion and differentiation of those memory cells were similar. Further, we determined that memory cells were highly functional regardless of whether they were derived from CD25 hi or CD25 lo effector cells, as shown by high levels of effector cytokine secretion upon ex vivo restimulation (Fig. 5E ).
CD25 expression identifies two transcriptionally distinct subsets of early effector cells
We used RNA sequencing (RNA-seq) to compare the gene expression profiles of CD25 hi and CD25 lo SMARTA effector cells undergoing different levels of TCR signaling at day 5 post-infection. Each population had a unique transcriptional signature, as shown by cluster analysis of genes that showed significant differential expression (Fig. 6A ). Among these genes was CD25 itself, which indicated that differences in CD25 expression were transcriptionally regulated and served as an internal control for the validity of the analysis (Fig. 6B) . CD25 hi early effector cells had increased expression of a number of NFAT-inducible genes, including Runx3 (32), Ifng (32), and Ppp3ca (33) , and other TCR-inducible genes, including Bhlhe40 (34) and Dusp22 (35) . Furthermore, gene expression in CD25
hi cells was indicative of enhanced T H 1 differentiation, as determined by expression of Prf1, Il12rb2, Tbx21, and Prdm1 (Blimp-1) (19, 36, 37) . IL12rb2 expression has also been associated with TCR signal strength (38) . In contrast, CD25 lo effector cells had increased expression of genes related to the regulation of T cell activation such as Btla (39), Egr2, and Egr3 (40) ; genes associated with memory T cell formation such as Tcf7 (TCF-1) (41, 42), Pou2af1 (OCA-B) (43) , and Cd27 (44); and genes associated with Tfh differentiation such as Cebpa, Tcf7, Il6st, Id3, and Il6ra (Fig. 5B) (18, 41, 45 ). Differential expression of key genes was confirmed via RT-PCR (Fig. 6C) .
Decreased SHP-1, a key TCR signaling modulator, reduces Tfh differentiation
To modulate TCR signal strength in primary CD4 + T cells, we targeted the protein tyrosine phosphatase SHP-1 via shRNA. Because SHP-1 is a key regulator of the activity of TCR proximal tyrosine kinases, including ZAP-70 (46), we hypothesized that SHP-1 KD would result in enhanced and/or sustained TCR signaling. We expressed two different mir30-flanked shRNAs in retroviral expression plasmids, both specific for SHP-1, that had been previously described and displayed significant SHP-1 KD (30 to 80%) when expressed in EL-4 cells ( fig. S6A) (47) . We then generated bone marrow chimeras by transducing SMARTA bone marrow with SHP-1 shRNA retroviral vectors (SHP-1 KD), or an empty vector (EV) control, and transplanting it into irradiated Rag −/− recipients. Eight to 10 weeks later, cells were stimulated in vitro with DCs presenting GP 61-80 and tested for the presence of pZAP-70. For both shRNA constructs, SHP-1 KD resulted in more rapid induction and sustained maintenance of pZAP-70 ( fig. S6B ), indicating an impact on TCR signal strength. GFP + (SHP-1 KD or EV) and GFP − (WT) cells from the chimeras were adoptively transferred into B6 recipient mice, followed by LCMV infection. This allowed us to compare SHP-1 KD and EV SMARTA responses in different hosts and responses by transduced (GFP + ) and nontransduced (GFP − ) SMARTA cells in the same host. As early as day 3 post-infection, a T H 1 bias was present in SHP-1 KD SMARTA cells, evidenced by increased levels of CD25 and Tim-3 compared with WT and EV controls (Fig. 7A) . SHP-1 KD did not affect the overall activation of the SMARTA CD4 + T cells, as measured by CD44 and CD62L expression (Fig. 7B) . Day 8 effector cells also evidenced a T H 1 bias, as determined by a decrease in the proportion of effector cells expressing CXCR5 and an increase in the proportion of effector cells expressing Ly6C (Fig. 7, C and D) . The bias away from Tfh differentiation persisted into memory, as SHP-1 KD resulted in significantly fewer Tfh-like memory cells (Fig. 7C) . However, at both effector and memory time points, the overall number of SMARTA was not significantly altered by SHP-1 KD, indicating that the decrease in Tfh was compensated by an increase in T H 1. In support of this, SHP-1 KD cells produced the T H 1 cytokine IFN- at a higher frequency and an increased level on a per cell basis than their WT counterparts (Fig. 7E) . We concluded that effector and memory CD4 + T cell differentiation is governed, at least in part, by TCR signal strength.
of 12
DISCUSSION
Our results find a key role for TCR signal strength, as regulated by SHP-1, in determining clonal differences in both T helper differentiation (T H 1 versus Tfh) and memory formation. The TCR has previously been shown to influence T helper cell differentiation (11, 13, 15) . Strong TCR signals favor T H 1 over T H 2 differentiation (11) , and the extent of T H 1 effector function and polarization is dependent on TCR signal strength (26) . The TCR also plays a role in the differentiation of T H 1 and Tfh cells. In one study, high-affinity TCRs favored the differentiation of Tfh (13) , whereas in a second study, Tfh differentiation corresponded to long TCR/MHC dwell times (14) . More recently, it was found that limiting TCR signaling in T cells selectively impaired Tfh differentiation while leaving T H 1 responses relatively untouched (15) . In contrast, our findings demonstrate a correlation + SMARTA cells in the spleen and the MFI after intracellular antibody staining for the presence of Bcl-6 and T-bet. Error bars indicate SEM, and statistical significance was determined by Student's t test (n = 3 to 5 mice per group, representative of at least three independent experiments). *P < 0.05, **P < 0.01, ***P < 0.001.
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of stronger TCR signals and terminal T H 1 differentiation, whereas the differentiation of both Tfh and T H 1 with memory potential required comparatively weaker TCR signals. Several possibilities may explain these differences. First, although we show that TCR signaling distinguishes terminal effector cells from memory precursors, it is not clear how it might influence the differentiation of T H 1 and Tfh derived from CD25 lo effector cells. Second, the role of the TCR may be influenced by antigen availability, antigen localization, or the infectiondependent inflammatory environment. Third, TCR signaling is unlikely to be uniform throughout the primary response, and the impact of altering TCR signaling may depend on the approach. IL-2 has been shown to play an important role in the generation of T H 1 cells (15) and effector and memory CD4 + memory T cells that home to tertiary organs (30, 31) . In contrast to the preferential survival of CD25 lo effector T cell in circulation and in secondary lymphoid organs, CD25 hi effector cells gave rise to liver-residing memory T cells with equal efficiency to CD25 lo effector cells. This may reflect the variable role of IL-2 in driving the formation of these memory populations. CD25 is expressed by virtually all T cells during early activation. It is not known whether IL-2 signaling is required for tissue-resident memory T cell development only during the early phases of the effector response or whether sustained IL-2 signaling is required throughout the effector response. Given the heterogeneity of the expression of the high-affinity IL-2 receptor, it will be of interest to define these differences and to determine whether the TCR mechanistically controls T cell fate, at least in part, by controlling CD25 expression. The fate of individual clones within the primary immune response is highly heterogeneous. Single antigen-specific CD4 + precursor T cells can give rise to a clonally uniform T helper phenotype but with a high amount of variability from clone to clone (14) . This suggests that T helper fate decisions occur very early in the immune response but that naïve precursors T cells activated under similar in vivo conditions can give rise to highly distinct differentiation programs. Fate tracking of single CD4 + T cell precursors and their progeny revealed heterogeneity in T helper differentiation even between precursor cells that expressed the same TCR (48) . These results support our finding that differences in CD25 expression and ZAP-70 phosphorylation reflect heterogeneity in TCR signal strength even within a monoclonal T cell population. We speculate that the activity of TCRmediated differentiation may be affected and shaped by a number of environmental factors, including cytokines, costimulatory molecules, the antigen presenting cell, and antigen dose. Future studies are required to determine the factors that can give rise to differential activation events among T cells even when the TCR is the same.
There are several limitations to the interpretation of this study. Although we report differences in TCR signal strength in vitro, it is important to note that the in vitro initiation of TCR signals may not fully predict the heterogeneity of the in vivo response. It is likely that in vivo activation results from multiple or prolonged contacts with antigen. Furthermore, in vivo activation may occur in microenvironments that have variable concentrations of cytokines and other accessory signals. Our study does not distinguish between TCR signal strength and signal duration, and differences in antigen recognition by naïve T cells during the earliest phases of the immune response may have a distinct influence on memory formation as compared with antigen recognition by effector T cells during the peak of the infection or in the late phases of the effector response. In addition, TCR signaling is highly complex, and qualitatively distinct TCR signals may result from heterogeneity in antigen recognition during the polyclonal response. Future studies are needed to determine the impact of modulating multiple components of TCR signaling on CD4 + memory T cell differentiation.
MATERIALS AND METHODS
Design
The objective of this study was to explore the role of TCR signal strength in determining the differentiation of effector and memory CD4 + T cells in vivo. Flow cytometry was used to assess the activation, differentiation, and subsequent survival of CD4 + T cells after acute viral infection within laboratory mice. Cellular analysis was performed during the early T cell effector phase at the peak of the effector response and after memory formation. Techniques for the modulation of gene expression (shRNA) were used to confirm the results of observational studies. The sample size (n = 3 to 5) for the in vivo experiments was determined Results are representative of at least two independent experiments (n = 3 to 4 mice per group). *P < 0.05, **P < 0.01, ****P < 0.0001.
to be the optimal size for statistical analysis while using an appropriate number of laboratory mice and allowing for independent repeats. The investigators were not blinded when conducting or analyzing the experiments outlined in this study, the mice were randomly assigned to the different treatments, and repeat experiments were carried out in both male and female cohorts, with no apparent sex differences.
Mice and infections C57BL/6 (6 to 8 weeks old) mice were purchased from the Jackson Laboratories. SMARTA (49), Rag1-deficient, and SM mice were maintained in our colony at the University of Utah. C7 and C26 mice were generated at the University of Utah Transgenic Core Facility by standard microinjection techniques using a T cell-specific expression vector, VA-hCD2, in which the Tcrb gene was placed under the control of the human CD2 promoter and a 3′ locus control region of the Cd2 gene (50). They were then bred with the previously generated SM line (20) to produce a full TCR transgenic line on a Tcra −/− background. Mice are currently being backcrossed to a C57BL/6 background. LCMV Armstrong 53b was grown in baby hamster kidney (BHK) cells, titered in Vero cells, and injected intraperitoneally into recipient mice at a dose of 2 × 10 5 plaque-forming units. All mouse experiments were performed in accordance with protocols approved by the Institutional Animal Care and Use Committee at the University of Utah.
Cell lines and retroviral transductions
We previously generated a panel of TCRs (20) cloned into MigR1. In this construct, the TCRa and TCRb sequences are separated by a cis-acting hydrolyzing element, P2A, that allows bicistronic expression (27) and has an internal ribosomal entry site-dependent mCherry reporter. Using previously described methods (28) , replicationincompetent retroviruses were used to transduce the 58 
Cell preparations and flow cytometry
Splenocyte and liver single-cell suspensions were generated as previously described (8) and placed in cell culture media. Untouched CD4 + T cells from SMARTA, C7, and C26 mice were isolated via magnetic beads (Miltenyi Biotec) and injected intravenously into B6 mice 1 day before LCMV infection. For cell surface stains, single-cell suspensions were incubated with fluorescently conjugated antibodies diluted in antibody-staining buffer [phosphate-buffered saline (PBS) containing 1% fetal bovine serum (FBS)] at 4°C for 30 to 45 min. For intracellular cytokine assays, splenocytes were restimulated for 4 hours with 1 M GP 61-80 peptide from LCMV (GLKGPDIYK-GVYQFKSVEFD) at 37°C in the presence of Brefeldin A (1 l/ml; GolgiPlug), permeabilized with a kit (BD Biosciences), and stained with fluorescently labeled antibodies specific to the indicated cytokines. Transcription factor analysis was performed using the Foxp3 Fixation/ Permeabilization Buffer and accompanying protocol (eBioscience). To probe for phosphorylation events via flow cytometry, cells were immediately fixed after extraction from the animal and formation of a single-cell suspension using prewarmed (37°C) 1.5% paraformaldehyde for 10 min at 37°C, followed by permeabilization in ice-cold 100% MeOH for 10 min. Cells were then incubated with antibodies to surface and intracellular targets from 45 to 60 min. Tetramer staining was done for 1 hour at room temperature in RPMI 1640 containing 2% FBS and 0.1% sodium azide, followed by cell surface staining.
Retrogenic bone marrow chimeras
To generate TCR retrogenic bone marrow chimeras, we used the above-described TCR expression constructs to generate retrovirus and then transduced TCR-expressing retroviruses into Rag1-deficient bone marrow cells using the described methods (28) . We then injected bone marrow cells intravenously into irradiated (450 rads) Rag1 
Isolation of CD25
hi and CD25 lo early effector cells C57BL/6 mice received 1 to 10 × 10 4 SMARTA CD4 + T cells, followed by LCMV infection 1 day later. At days 3 or 5 post-infection, single-cell splenocyte suspensions were stained with a nondepleting biotinylated anti-CD25 antibody (eBio7D4, eBioscience) (51) for 20 min on ice in a magnetic-activated cell sorting staining buffer (PBS with 0.5% bovine serum albumin and 1 mM EDTA), followed by incubation with anti-Biotin MicroBeads (Miltenyi Biotec) for an additional 20 min on ice. CD25 hi and CD25 lo CD4 + T cells were separated via magnetic sorting columns (Miltenyi Biotec).
RNA sequencing CD25
hi and CD25 lo SMARTA CD4 + T cells (Thy1.1 + ) were FACSsorted from splenocytes 5 days after LCMV infection. RNA was then extracted using a kit (miRNeasy, Qiagen). Library preparation and RNA-seq were performed by the University of Utah DNA Sequencing Core Facility (NuGEN Ovation RNA-Seq System v2, HiSeq 50 Cycle Single Read) on a HiSeq 2000 (Illumina). A realtime analysis software (RTA v1.18.61) performed base calling and assigned a quality score to each base for each cycle. Reads were aligned to hg19 + splice junctions using NovoAlign. Spliced alignments were converted back to genomic space, sorted, and indexed using Useq 8.8.9 SamTranscriptomeParser. Differentially expressed genes were determined using DefinedRegionDifferentialSeq. Sequencing results were analyzed, and differences in gene expression were calculated by the University of Utah Bioinformatics Shared Resource. Sequencing raw data are available in the Gene Expression Omnibus (GEO) repository (GSE114884).
Reverse transcription polymerase chain reaction RNA was isolated using TRIzol (Life Technologies) and converted to complementary DNA using SuperScript III First-Strand Synthesis System (Thermo Fisher Scientific). Semiquantitative RT-PCR reactions were carried out using Power SYBR Green PCR Master Mix (Life Technologies) and run on the LightCycler 480 (Roche).
SHP-1 KD
Retroviral vectors (pMig-R1) were used to express shRNA KD constructs specific for SHP-1 (SHP-1 KD) as previously described (47) . A human microRNA (mir30) flanking sequence allowed for optimal expression and processing of siRNA (52 ) into B6 recipient mice that were subsequently infected with LCMV the next day (53) .
Statistical analysis
Data analysis was performed using Prism (GraphPad) software.
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